Transfusion-associated immunomodulation: Quantitative changes in cytokines as a measure of immune responsiveness after one time blood transfusion in neurosurgery patients

Asian Journal of Transfusion Science

Volumn 4, Issue 2, 2010, Pages 78-85

  Pandey, Prashant ^a   Chaudhary, Rajendra ^a   Aggarwal, Amita ^a   Kumar, Raj ^a   Khetan, Dheeraj ^a   Verma, Anupam ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cytokines production; immunologic changes; leukofiltration; soluble mediators; transfusion

Indexed keywords

EID: 84863994443     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.67021     Document Type: Article

References (36)

1. Bordin JO, Blajchman MA. Transfusion associated immunomodulation. Rossi's Principles of Transfusion Medicine. 3rd ed. Philadelphia: Lippencott Williams and Williams; 2002. p. 867-877
2. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-259
3. Opelz G, Terasaki P. Importance of preoperative (not preoperative) transfusions for cadaveric kidney transplants. Transplantation 1981;31:106-108
4. Unander AM. The role of immunization treatment in preventing recurrent abortion. Transfus Med Rev 1992;6:1-16.
5. Gafter U, Sredni B, Segal J, Kalechman Y. Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J Clin Immunol 1997;17:408-419
6. Peters WR, Fry RD, Fleshman JW, Kodner IJ. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum 1989;32:749-753
7. Blumberg N, Heal JM. Effects of transfusion on immune function-cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-379
8. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-845
9. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-1867
10. Moore FA, Moore EE, Sauaia A. Blood transfusion: An independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132:620-624
11. Corwin HL. Blood transfusion in the critically ill patient. Dis Mon 1999;45:409-426
12. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1705-1721
13. Bordin JO, Blajchman MA. Blood transfusion and tumor growth in animal models. In: Vamvakas EC, Blajchman MA, editors. Immunomodulatory Effects of Blood Transfusion. Bethesda: AABB Press; 1999. p. 29-42.
14. Ghio M, Contini P, Mazzei C, Merlo A, Filaci G, Setti M, et al. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: Do they play a role in autologous blood transfusion? Transfusion 2001;41:988-996
15. Babcock GF, Alexander JW. The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse. Transplantation 1996;61:465-468
16. Blumberg N, Heal JM. The transfusion immunomodulation theory: The Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism. Semin Hematol 1996;33:329-340
17. Kirkley SA, Cowles J, Pellegrini VD, Harris CM, Boyd AD, Blumberg N. Blood transfusion and total joint replacement surgery: T helper 2 (TH2) cytokine secretion and clinical outcome. Transfus Med 1998;8:195-204.
18. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991;31:212-217
19. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-1333
20. Wallis JP, Chapman CE, Orr KE, Clark SC, Forty JR. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002;42:1127-1134
21. Fung MK, Moore K, Ridenour M, Mook W, Triulzi DJ. Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery. Transfusion 2006;46:386-391
22. Kalechman Y, Gafter U, Sobelman D, Sredni B. The effect of a single whole-blood transfusion on cytokine secretion. J Clin Immunol 1990;10:99-105.
23. Elsässer-Beile U, von Kleist S, Gallati H. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures J Immunol Methods 1991;139:191-195
24. Mincheff MS, Meryman HT, Kapoor V, Alsop P, Wotzel M. Blood transfusion and immunomodulation: A possible mechanism. Vox Sang 1993;65:18-24.
25. Klementschitsch P, van de Maas AH, Brand A. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: A prospective study. Transfusion 1997;37:126-134
26. Sharma AD, Slaughter TF, Clements FM, Sreeram G, Newman MF, Phillips-Bute B, et al. Association of leukocyte-depleted blood transfusions with infectious complications after cardiac surgery. Surg Infect (Larchmt) 2002;3:127-133
27. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992;53:1281-1294
28. Bordin JO, Chiba AK, Carvalho KI, Takata ET, Falcão RP, Garcia AB, et al. The effect of unmodified or prestorage white cell-reduced allogeneic red cell transfusions on the immune responsiveness in orthopedic surgery patients. Transfusion 1999;39:718-723
29. Freitas ID, Fernández-Somoza M, Essenfeld-Sekler E, Cardier JE. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest 2004;125:2238-2246
30. Bahr GM, Capron A, Dewulf J, Nagata S, Tanaka M, Bourez JM, et al. Elevated serum level of Fas ligand correlates with the asymptomatic stage of human immunodeficiency virus infection. Blood 1997;90:896-898
31. Lapinski TW, Kowalczuk O, Prokopowicz D , Chyczewski L. Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients. World J Gastroenterol 2004;10:3650-3653
32. Hori Y, Wada H, Mori Y, Shimura M, Hiyoyama K, Nakasaki T, et al. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation. Am J Hematol 1999;61:21-25
33. Puppo F, Ghio M, Contini P, Mazzei C, Indiveri F. Fas, Fas ligand and transfusion immunomodulation. Transfusion 2001;41:416-418
34. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type1/ type 2 T-helper cell balance, suggesting down-regulation of cell mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996;119:316-325
35. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988;75:789-792
36. Vamvakas EC, Carven JH. RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronary artery bypass graft surgery: The effects of confounding factors. Transfusion 2000;40:832-839